Biological, biochemical, and molecular characterization of a new clinical Trichophyton rubrum isolate resistant to terbinafine

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 6, 2006, Pages 2234-2236

  Osborne, Colin S ^a,b   Leitner, Ingrid ^a   Hofbauer, Bettina ^a   Fielding, Ceri A ^a,c   Favre, Bertrand ^a,d   Ryder, Neil S ^a,b  

^a Novartis Institutes for Biomedical Research   (Austria)

^b NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

^c CARDIFF UNIVERSITY   (United Kingdom)

^d LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; BUTENAFINE; FLUCONAZOLE; GRISEOFULVIN; ITRACONAZOLE; LEUCINE; NAFTIFINE; PHENYLALANINE; SQUALENE MONOOXYGENASE; TERBINAFINE; TOLNAFTATE;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BIOCHEMISTRY; CONTROLLED STUDY; DRUG MECHANISM; FUNGAL GENE; FUNGAL STRAIN; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MISSENSE MUTATION; MOLECULAR BIOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TRICHOPHYTON RUBRUM;

AMINO ACID SUBSTITUTION; ANTIFUNGAL AGENTS; BASE SEQUENCE; CLONING, MOLECULAR; COLONY COUNT, MICROBIAL; DRUG RESISTANCE, FUNGAL; ERGOSTEROL; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; NAPHTHALENES; SEQUENCE ANALYSIS, DNA; SQUALENE MONOOXYGENASE; TRICHOPHYTON;

EID: 33744489064     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01600-05     Document Type: Article

References (20)

1. Bradley, M. C., S. Leidich, N. Isham, B. E. Elewski, and M. A. Ghannoum. 1999. Antifungal susceptibilities and genetic relatedness of serial Trichophyton rubrum isolates from patients with onychomycosis of the toenail. Mycoses 42:105-110.
2. Chenna, R., H. Sugawara, T. Koike, R. Lopez, T. J. Gibson, D. G. Higgins, and J. D. Thompson. 2003. Multiple sequence alignment with the Clustal series of programs. Nucleic Acids Res. 31:3497-5300.
3. da Silva Ferreira, M. E., J. L. Capellaro, E. dos Reis Marques, I. Malavazi, D. Perlin, S. Park, J. B. Anderson, A. L. Colombo, B. A. Arthington-Skaggs, M. H. Goldman, and G. H. Goldman. 2004. In vitro evolution of itraconazole resistance in Aspergillus fumigatus involves multiple mechanisms of resistance. Antimicrob. Agents Chemother. 48:4405-4413.
4. Favre, B., and N. S. Ryder. 1996. Characterization of squalene epoxidase activity from the dermatophyte Trichophyton rubrum and its inhibition by terbinafine and other antimycotic agents. Antimicrob. Agents Chemother. 40:443-447.
5. Favre, B., and N. S. Ryder. 1997. Differential inhibition of fungal and mammalian squalene epoxidases by the benzylamine SDZ SBA 586 in comparison with the allylamine terbinafine. Arch. Biochem. Biophys. 340:265-269.
6. Favre, B., and N. S. Ryder. 1997. Cloning and expression of squalene epoxidase from the pathogenic yeast Candida albicans. Gene 189:119-126.
7. Favre, B., M. A. Ghannoum, and N. S. Ryder. 2004. Biochemical characterization of terbinafine-resistant Trichophyton rubrum isolates. Med. Mycol. 42:525-529.
8. Fernandez-Torres, B., H. Vazquez-Veiga, X. Llovo, M. Pereiro, Jr., and J. Guarro. 2000. In vitro susceptibility to itraconazole, clotrimazole, ketoconazole and terbinafine of 100 isolates of Trichophyton rubrum. Chemotherapy 46:390-394.
9. Gupta, A. K., and Y. Kohli. 2003. Evaluation of in vitro resistance in patients with onychomycosis who fail antifungal therapy. Dermatology 207:375-380.
10. Gupta, A. K., and Y. Kohli. 2003. In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and non-dermatophytes, and in vitro evaluation of combination antifungal activity. Br. J. Dermatol. 149:296-305.
11. Hofbauer, B., I. Leitner, and N. S. Ryder. 2002. In vitro susceptibility of Microsporum canis and other dermatophyte isolates from veterinary infections during therapy with terbinafine or griseofulvin. Med. Mycol. 40:179-183.
12. Leber, R., S. Fuchsbichler, V. Klobucnikova, N. Schweighofer, E. Pitters, K. Wohlfarter, M. Lederer, K. Landl, C. Ruckenstuhl, I. Hapala, and F. Turnowsky. 2003. Molecular mechanism of terbinafine resistance in Saccharomyces cerevisiae. Antimicrob. Agents Chemother. 47:3890-3900.
13. Loeffler, J., and D. A. Stevens. 2003. Antifungal drug resistance. Clin. Infect. Dis. 6:S313-S341.
14. Mukherjee, P. K., S. D. Leidich, N. Isham, I. Leitner, N. S. Ryder, and M. A. Ghannoum. 2003. Clinical Trichophyton rubrum strain exhibiting primary resistance to terbinafine. Antimicrob. Agents Chemother. 47:82-86.
15. National Committee for Clinical Laboratory Standards. 2000. Reference method for broth dilution antifungal susceptibility testing of conidium-forming filamentous fungi. Approved standard M38-A. NCCLS, Wayne, PA.
16. Osborne, C. S., B. Hofbauer, B. Favre, and N. S. Ryder. 2003. In vitro analysis of the ability of Trichophyton rubrum to become resistant to terbinafine. Antimicrob. Agents Chemother. 47:3634-3636.
17. Osborne, C. S., I. Leitner, B. Favre, and N. S. Ryder. 2005. Amino acid substitution in Trichophyton rubrum squalene epoxidase associated with resistance to terbinafine. Antimicrob. Agents Chemother. 49:2840-2844.
18. Perea, S., A. W. Fothergill, D. A. Sutton, and M. G. Rinaldi. 2001. Comparison of in vitro activities of voriconazole and five established antifungal agents against different species of dermatophytes using a broth macrodilution method. J. Clin. Microbiol. 39:385-388.
19. Sanglard, D. 2002. Resistance of human fungal pathogens to antifungal drugs. Curr. Opin. Microbiol. 5:379-385.
20. Sanglard, D. 2002. Clinical relevance of mechanisms of antifungal drug resistance in yeasts. Enferm. Infecc. Microbiol. Clin. 20:462-469.